Join Qinecsa at 31st Pharmacovigilance 2023 to discuss the latest developments in pharmacovigilance, drug safety & risk management. Humaira Qureshi, President, Qinecsa Solutions, will
Stanley Capital Partners LLP (SCP) has announced the acquisition of Commonwealth Informatics, Inc. (Commonwealth) by its portfolio company Qinecsa Solutions UK Ltd. (Qinecsa), a leading
A specialty pharma company were experiencing complaints regarding their existing Medical Information Call Center (MICC) due to a high call abandon rate. Qinecsa provided Medical
Pharmacovigilance consulting is essential throughout the entire lifecycle of both commercial and clinical products. At Qinecsa, a company with a strong focus and heritage on
Dr Andrew Rut, Senior Executive at Qinecsa will be attending the 6th ISoP Seminar on 5-6 December in Boston, US. The seminar theme is ‘Intelligent
A longstanding client approached Qinecsa with a business-critical mission to support case processing activities during the COVID pandemic. Qinecsa deployed a dedicated screening, recruitment, and
A global pharma company needed pharmacovigilance expertise following a European Medicines Agency inspection which resulted in several critical findings. They required a robust pharmacovigilance system
The World Drug Safety Congress Americas brings together over 1000 top leaders and stakeholders in biopharma to discuss the key challenges they are facing in
The World Drug Safety Congress Europe brings together over 700 key thought leaders to explore the top challenges within pharmacovigilance. This year’s agenda will explore
Patient safety is at the forefront of pharmacovigilance. In a demanding and constantly evolving field, life science companies need expert partners with the right people,
2 Leman Street,
London, E1W 9US
United Kingdom
Company number: 13916274
